NCT07851935

Brief Summary

This study aims to compare the effectiveness of irrigation of 0.5% bupivacaine versus normal saline at the gallbladder surgical bed in reducing postoperative pain following laparoscopic cholecystectomy for acute cholecystitis. Postoperative pain remains a common concern despite the minimally invasive nature of laparoscopic surgery. The study evaluates pain intensity at 4, 8, and 12 hours after surgery using the Visual Analogue Scale (VAS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2025

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 1, 2026

Completed
Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

7 months

First QC Date

September 25, 2026

Last Update Submit

September 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pain Intensity at 12 Hours

    Pain intensity measured on a 0-10 Visual Analogue Scale (VAS), where 0 means no pain and 10 means the worst imaginable pain. Lower scores indicate less pain.

    12 hours after surgery

Secondary Outcomes (1)

  • Number of Participants With Adverse Effects

    Up to 12 hours after surgery

Study Arms (2)

Normal Saline Irrigation Group

PLACEBO COMPARATOR

Patients received 20 mL of 0.9% normal saline irrigated over the gallbladder bed using the same technique and timing as the bupivacaine group. Postoperative analgesia was standardized with scheduled intravenous non-steroidal anti-inflammatory drugs, with weak opioids as rescue.

Drug: Normal Saline 0.9%

Bupivacaine Irrigation Group

EXPERIMENTAL

Patients received 20 mL of 0.5% bupivacaine irrigated over the gallbladder bed through the lateral-most port immediately after specimen retrieval, before desufflation and port closure. Postoperative analgesia was standardized with scheduled intravenous non-steroidal anti-inflammatory drugs, with weak opioids as rescue.

Drug: Bupivacaine 0.5%

Interventions

20 mL of 0.5% bupivacaine irrigated over the gallbladder bed through the lateral-most port after specimen retrieval, before desufflation and port closure.

Bupivacaine Irrigation Group

20 mL of 0.9% sodium chloride irrigated over the gallbladder bed using the same technique and timing as the bupivacaine group.

Normal Saline Irrigation Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18 to 60 years
  • Acute cholecystitis confirmed by clinical findings (epigastric pain, abdominal tenderness, positive Murphy sign), ultrasound or CT findings (gallbladder wall thickening, pericholecystic fluid), and raised total leucocyte count and C-reactive protein
  • Planned for laparoscopic cholecystectomy
  • American Society of Anesthesiologists (ASA) physical status I or II
  • Presentation within one week of symptom onset
  • Able to provide written informed consent

You may not qualify if:

  • Known allergy to amide local anaesthetics
  • Uncontrolled hypertension
  • Documented psychiatric disorder
  • Gallbladder empyema, mucocele, or perforation
  • Conversion to open cholecystectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Ziauddin Hospital

Karachi, Sindh, 75600, Pakistan

Location

MeSH Terms

Conditions

Cholecystitis, AcutePain, Postoperative

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

CholecystitisGallbladder DiseasesBiliary Tract DiseasesDigestive System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

September 25, 2026

First Posted

October 1, 2026

Study Start

October 1, 2025

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

October 1, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

De-identified individual participant data on the study outcomes (Visual Analogue Scale pain scores) and baseline characteristics will be shared on reasonable request.

Shared Documents
STUDY PROTOCOL
Time Frame
Starting after publication of the results and available for 5 years.
Access Criteria
Requests should be sent to the Principal Investigator with a brief research proposal. Data will be shared after approval by the investigators, subject to Ziauddin University Ethics Review Committee requirements.

Locations